Curofy
ACEI/ARBs Improve AMI Outcomes Regardless of Kidney Function
For acute myocardial infarction (AMI) survivors, angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) treatment is associated with improved long-term survival, according to research.
See this content immediately after install